How would you manage a patient with a recent diagnosis of advanced DLBCL (non-GCB subtype) who has baseline grade 3 neuropathy?
1 Answer
Mednet Member
Medical Oncology · CompHealth
Answered on
Avoid neurotoxic agents.
Substitute pola; avoid vincristine.
Join for free or sign in to see the full answer